07/02/2025
3:30 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
8:55 AM | ACORN BIOVENTURES, L.P. (Filed by)
Candel Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Nabel Gary J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CADL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/24/2025
3:30 PM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
8:20 AM | Candel Therapeutics (Filer)
| Form 424B5 | |
06/24/2025
8:27 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
7:32 AM | Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:33 AM | Candel Therapeutics (Issuer)
Nguyen Diem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:33 AM | Candel Therapeutics (Issuer)
Nabel Gary J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:34 AM | Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:35 AM | Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:36 AM | Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:37 AM | Candel Therapeutics (Issuer)
Gaeta Renee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:38 AM | Benz Edward J. JR (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:31 PM | Candel Therapeutics (Issuer)
Radhakrishnan Maha (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2025
7:11 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
7:10 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2025
4:12 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
7:30 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
3:15 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2025
8:57 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
3:35 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4/A | |
03/20/2025
3:35 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:36 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:36 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
3:12 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:28 PM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
3:29 PM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
3:29 PM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
3:29 PM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Post-Halving = Profit Season (Here’s How to Win It) (Ad) It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential.
We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks.
Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap.
And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it. The Most Profitable Phase of Crypto Just Started - PLUS Claim your $10 in Bitcoin |
03/17/2025
3:29 PM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
3:45 PM | Candel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2025
12:35 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:32 PM | Candel Therapeutics (Subject)
Northpond Ventures, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
3:30 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
5:25 AM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:09 PM | Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:18 AM | Candel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:03 AM | Candel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
7:05 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:27 AM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:27 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:28 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:28 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:29 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/30/2024
6:37 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
12:59 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:11 PM | Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
11:30 AM | Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
| Form SC 13G | |
12/13/2024
5:12 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:30 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
3:36 PM | Candel Therapeutics (Filer)
| Form 424B5 | |
12/12/2024
3:55 PM | Candel Therapeutics (Filer)
| Form 424B5 | |
12/11/2024
6:45 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
5:44 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:46 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:47 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:48 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:48 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
8:12 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
8:13 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
8:15 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
8:17 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
5:24 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
2:07 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Post-Halving = Profit Season (Here’s How to Win It) (Ad) It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential.
We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks.
Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap.
And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it. The Most Profitable Phase of Crypto Just Started - PLUS Claim your $10 in Bitcoin |
11/14/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:58 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
5:08 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
5:41 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:59 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:19 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
4:16 PM | Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free CADL Stock Alerts